SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-011874
Filing Date
2018-09-14
Accepted
2018-09-14 16:12:01
Documents
55
Period of Report
2018-07-31

Document Format Files

Seq Description Document Type Size
1 10-Q csbr10-q7312018.htm 10-Q 553604
2 EXHIBIT 31.1 csbrq1731201810-qex311.htm EX-31.1 10385
3 EXHIBIT 31.2 csbrq1731201810-qex312.htm EX-31.2 10511
4 EXHIBIT 32.1 csbrq1731201810-qex321.htm EX-32.1 8132
  Complete submission text file 0001628280-18-011874.txt   3536399

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT csbr-20180731.xml EX-101.INS 669790
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20180731.xsd EX-101.SCH 33102
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT csbr-20180731_cal.xml EX-101.CAL 61605
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20180731_def.xml EX-101.DEF 118488
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20180731_lab.xml EX-101.LAB 421293
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20180731_pre.xml EX-101.PRE 239766
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-11504 | Film No.: 181071256
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1